Better cancer care for the animals who share our lives.
We are bringing percutaneous cryoablation to U.S. veterinary practices. Working towards the commons goal to make a less invasive cancer therapy the standard for companion animals.
A better way to treat cancer in dogs and cats.
Roughly half of dogs over the age of ten will develop cancer. About a third of older cats will die of it. Today, that means surgery with wide margins, weeks of radiation, or cytotoxic chemotherapy.
CryoKnife exists to give clinicians a fourth option, an image-guided, minimally invasive, and rooted in a decade of human-oncology evidence. We started here because we believe the same standard of care our families receive should be available to the animals living alongside them.
Patented, image-guided, precise.
At the heart of CryoKnife is a patented four layer ablation needle that creates a focused -40 °C zone at the tip while keeping the surrounding shaft at a safe normal tissue temperature.
Real-time CT or ultrasound imaging makes the ice ball visible throughout the procedure, so the clinician shapes the ablation directly around the tumor, while preserving the healthy tissue, vessels, and structures next to it.
- Probe sizesR-13 · R-17 · R-24
- Freeze temperature-40 °C ± 3 °C
- GuidanceCT or ultrasound
- AnesthesiaLocal or general
Two years. Seventy hospitals. Fifteen hundred cases.
Cryoablation has been used in human oncology centers in China for over a decade. Over the past two years, the same technology has been adapted and deployed across roughly seventy specialty veterinary hospitals, with more than fifteen hundred procedures performed across dogs and cats.
Procedures performed
Across a range of tumor types and sizes, from cutaneous mast cell to liver and nasal.
Specialty hospitals
Already trained on the system and incorporating cryoablation into oncology workflows.
Clinical use
In active use across partner hospitals — with ongoing outcomes data collection.